AVTR vs IART
AVTR: Global provider of mission-critical laboratory consumables, specialty chemicals, and biopharmaceutical manufacturing solutions serving life sciences, healthcare, and advanced technology markets worldwide. IART: Integra LifeSciences is a medical technology company specializing in regenerative medicine, neurosurgery, and advanced surgical instrumentation.
Side-by-side fundamentals
| Metric | AVTR | IART | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $10.95 | $18.82 | |
| Market cap as of 2026-07-23 | $7.5B | $1.5B | |
| PEG as of 2026-07-23 | n/a | -0.00 | |
| Net margin as of 2026-07-23 | -8.4% | -30.1% | AVTR higher |
| Gross margin as of 2026-07-23 | +32.1% | +57.1% | IART higher |
| Operating margin as of 2026-07-23 | -4.6% | -28.4% | AVTR higher |
| ROE as of 2026-07-23 | -9.6% | -47.6% | AVTR higher |
| ROA as of 2026-07-23 | -4.6% | -13.7% | AVTR higher |
| Debt / equity as of 2026-07-23 | 0.68 | 1.79 | AVTR lower |
| Revenue growth (YoY) as of 2026-07-23 | -2.0% | +1.2% | IART higher |
| Revenue CAGR (3y) SEC XBRL | -4.5% | +1.6% | IART higher |
| Beta as of 2026-07-23 | 0.92 | 1.21 | |
| 1-year return as of 2026-07-22 close | -10.9% | +67.2% | IART higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.